Elm Street Ventures Investments

Elm Street Ventures has invested in 18 companies and its latest investment was Halda Therapeutics on Aug 11, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Halda Therapeutics is a Connecticut-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer.
$126M
Aug 11, 2024
-
CellFE is a California-based microfluidics-powered cell engineering company that develops gene editing molecules and cell therapies for the pharmaceutical industry.
$22M
Sep 26, 2023
-
P2 is a Connecticut-based chemical company that manufactures and supplies specialty ingredients for sectors including personal care and cosmetics.
-
Feb 22, 2023
-
Zid is a Saudi Arabia-based digital platform that offers retail enablement solutions for the E-commerce sector.
$7M
Mar 23, 2021
-
Cybrexa is a biotechnology company that develops and commercializes novel therapeutics for the treatment of patients with solid tumors and cancers.
$31.2M
Dec 28, 2020
-

Frequently Asked Questions about Elm Street Ventures

  1. What is Elm Street Ventures investing in?

    Elm Street Ventures has invested in 18 companies including Halda Therapeutics, CellFE and P2
  2. What company did Elm Street Ventures invest in?

    Elm Street Ventures invested in a total 18 companies including Halda Therapeutics, CellFE and P2
  1. What are the top 5 investments by Elm Street Ventures?

    The top companies in which Elm Street Ventures invested are Halda Therapeutics, CellFE, P2, Zid and Cybrexa